论文部分内容阅读
血管免疫母细胞淋巴腺病(angioim-munoblastic lymphadenopathy,AILD)是一种最近报道的具有充分临床病理特征性疾病。20％病例转变为恶性淋巴瘤,其临床表现及生物学特征与AILD相同。国内马明信首次报道2例AILD转变为淋巴瘤。本院于1993年10月5日收治1例AILD转变为经病理及免疫学证实的T细胞淋巴瘤。现报道及讨论如下。
Angioim-munoblastic lymphadenopathy (AILD) is a recently reported, clinically and clinically pathologically characterized disease. Twenty percent of cases have been converted to malignant lymphoma, with the same clinical features and biological characteristics as AILD. Ma Ming letter for the first time reported 2 cases of AILD into lymphoma. The hospital on October 5, 1993 admitted a case of AILD into pathologically and immunologically confirmed T-cell lymphoma. It is reported and discussed below.